During the last half of December, Surfing the NASH Tsunami is devoting itself to a NAFLD 2021 Year-in-Review. Episodes 62-64 each include ~20 minute segments of three longer interviews with Stakeholders who have made a dent in Fatty Liver disease in 2021.
[415]
In Episode 62, Louise Campbell and Roger Green discuss AI and liver histology with Dr. Mazen Noureddin, Director of the Fatty Liver Program at Cedars Sinai, Los Angeles, MRE and the larger evolution of non-invasive tests with Professor Alina Allen of the Mayo Clinic, and patient activism and what it takes to create and executive a study that appears in a refereed publication with Fatty Liver Foundation President and CEO Wayne Eskridge.